3 Reasons to Avoid AORT and 1 Stock to Buy Instead
ATLANTA , April 23, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that first quarter 2026 financial...
1 Stock Under $50 to Own for Decades and 2 We Avoid
Artivion, ANI Pharmaceuticals, and Privia Health Shares Are Soaring, What You Need To Know
Stocks making big moves yesterday: Levi's, Strategy, Vishay Precision, Celsius, and Artivion
Endospan's NEXUS branched endovascular stent graft system shown to effectively treat aortic arch disease, including chronic aortic dissections
Why Artivion (AORT) Stock Is Down Today
1 Healthcare Stock on Our Watchlist and 2 We Find Risky
Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks
1 Profitable Stock with Impressive Fundamentals and 2 That Underwhelm